Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement

JDOCvsXLVETF Comparison

ETF 1
JDOC

JPMorgan Healthcare Leaders ETF

This fund is part of
Global Blended Cap
-0.19%
VS
ETF 2
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
-0.77%

JPMorgan Healthcare Leaders ETF (JDOC) belongs to the Global Blended Cap segment. State Street Health Care Select Sector SPDR ETF (XLV) is part of the US Health Care segment. JDOC's top 3 sector exposures are Health Care and Consumer Discretionary. In contrast, XLV's top sector exposures are Health Care  JDOC is more expensive with a Total Expense Ratio (TER) of 0.65%, versus 0.08% for XLV. JDOC is down -5.74% year-to-date (YTD) with +$3M in YTD flows. XLV performs worse with -7.37% YTD performance, and +$904M in YTD flows. Run a side-by-side ETF comparison of JDOC and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

JDOC vs XLV performance and flow charts

Performance

-1.00.01.02.03.04.05.06.0%Mar 30Apr 7Apr 14Apr 21Apr 28

Cumulative Flows

-400 M-300 M-200 M-100 M0 M100 M200 M300 MMar 30Apr 7Apr 14Apr 21Apr 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/29/2026
1M3MYTD1Y3Y5Y
Perf.
JDOC
XLV
+0.62%-0.71%
-6.80%-6.82%
-5.74%-7.37%
+6.79%+4.34%
n/a+11.78%
n/a+27.17%
Flows
JDOC
XLV
+$1M-$209M
+$3M-$416M
+$3M+$904M
+$3M+$716M
--$4.50B
-+$7.16B
Volatility and drawdown
3M1Y3Y5Y
Volatility
JDOC
XLV
+15.10%+14.91%
+14.83%+15.81%
n/a+13.69%
n/a+14.58%
Max drawdown
JDOC
XLV
-8.98%-10.51%
-9.66%-10.51%
n/a-17.05%
n/a-17.05%
Max drawdown duration
JDOC
XLV
59d59d
97d59d
n/a444d
n/a444d
Trading data

Create an account to view trading data

Join for free
JDOC
XLV
Last sale
4/29/2026 at 2:12 PM
$54.19
$146.05
Previous close
04/29/2026
$54.71
$142.84
Consolidated volume
04/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

JDOC
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
JDOC
XLV
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/29/2026 at 2:12 PM
Live
Closed
JDOC
XLV
Last price
$54.19
$146.05
1D performance
-0.95%
+2.25%
AuM$10.91 M$37.43 B
E/R0.65%0.08%
Characteristics
JDOC
XLV
Management strategyActivePassive
ProviderJ.P. Morgan Asset ManagementState Street Investment Management
Benchmark-S&P Health Care Select Sector Index
N° of holdings5156
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateNovember 1, 2023December 16, 1998
ESGNoNo
Advertisement
Exposure

Countries

JDOC
USA
72.64%
Other
27.36%
XLV
USA
97.26%
Other
2.74%

Sectors

JDOC
Health Care
91.04%
Other
8.96%
XLV
Health Care
98.29%
Other
1.71%
Advertisement

Diversification

JDOC

Total weight of top 15 holdings out of 15

59.93%
XLV

Total weight of top 15 holdings out of 15

70.96%

Top 15 holdings

Data as of March 31, 2026
JDOC
JOHNSON&JOHNSON
9.06%
ABBVIE
6.94%
LILLY
6.62%
MERCK & CO INC
5.08%
ASTRAZENECA
4.89%
UNITEDHEALTH GRP
3.71%
BRISTOL-MYERS SQUIBB
3.49%
MEDTRONIC PLC
3.06%
CH1499059983
2.72%
DANAHER
2.54%
EDWARDS LIFESCIENCES
2.46%
BOSTON SCIENTIFIC
2.40%
REGENERON PHARMACEUTICALS
2.36%
CVS HEALTH CORP
2.35%
MCKESSON
2.25%
XLV
LILLY
13.74%
JOHNSON&JOHNSON
11.10%
ABBVIE
7.25%
MERCK & CO INC
5.63%
UNITEDHEALTH GRP
4.62%
AMGEN-T
3.57%
THERMO FISHER SCIENTIFIC
3.48%
ABBOTT LABS
3.37%
GILEAD SCIENCES
3.26%
INTUITIVE SURGICAL
3.09%
PFIZER
3.01%
BRISTOL-MYERS SQUIBB
2.33%
DANAHER
2.25%
VERTEX PHARMACEUTICALS
2.14%
STRYKER
2.13%
Frequently asked questions about JDOC and XLV

How have the JDOC and XLV ETFs performed in 2026?

As of April 29, 2026, JDOC is down -5.74% year-to-date (YTD), while XLV has lost -7.37%. That puts JDOC better performer ahead so far this year.

Which ETF is attracting more investor money: JDOC or XLV?

Year-to-date, the JDOC ETF saw +$3M in flows, compared to +$904M for XLV.

Which ETF is more volatile: JDOC or XLV?

Over the past year, JDOC had a volatility of 14.83%, while XLV experienced 15.81%.

Which ETF is bigger: JDOC or XLV?

As of April 29, 2026, JDOC holds $10.91 M in assets under management (AUM), while XLV manages $37.43 B.

What sectors do the JDOC and XLV ETFs invest in?

JDOC leans toward sectors like Health Care. Meanwhile, XLV focuses on Health Care.

What are the top holdings of the JDOC ETF and XLV ETF?

JDOC top holdings include JOHNSON&JOHNSON, ABBVIE and LILLY. XLV holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.

Which ETF is more diversified: JDOC or XLV?

JDOC holds 61 securities with 59.93% of its assets in the top 15. XLV has 59 securities and a top 15 weight of 70.96%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast